文献速递衰弱、肌少症与跌倒认知障碍与谵妄老年慢病共病管理

衰弱与共病在严重感染及痴呆风险中的作用:前瞻性多队列观察研究

The role of frailty and comorbidities in severe infections and the risk of dementia: a prospective, multicohort, observational study.
PubMed 文献 · Lancet Healthy Longev · 2026-04-09

BACKGROUND: Severe infections have been linked to an increased risk of dementia, but whether this association reflects pre-existing conditions that predispose individuals to infections and dementia remains unclear.…

要点

  • 严重感染与痴呆风险升高相关,调整衰弱后关联无明显减弱。
  • 衰弱、共病与其他年龄相关疾病与痴呆风险升高相关,但不能解释感染后痴呆风险。

核心结论

  • 衰弱、共病及其他年龄相关疾病与痴呆风险升高相关,但未能解释严重感染后观察到的痴呆风险升高。
  • 需要干预性研究检验针对感染能否降低痴呆发病率。

研究设计与样本

  • 前瞻性多队列观察研究,主要分析在UK Biobank队列进行,并在Whitehall II研究重复。
  • 基线采用Fried衰弱表型评估衰弱,采用Charlson共病指数及78种年龄相关疾病评估共病。
  • 随访包括基线后5年暴露期、2年洗脱期及至随访结束的最终期,痴呆 ascertainment 至2022年。

关键数值与推荐

  • 严重感染定义为住院治疗的感染,从关联的医院出院诊断中识别。
  • 痴呆结局从医院记录和死亡证明中确定,暴露期或洗脱期内记录痴呆者被排除。
  • 衰弱采用Fried衰弱表型评估,共病采用Charlson共病指数及78种年龄相关疾病评估。

临床怎么用

  • 对严重感染后出院的老年患者,应关注其后续痴呆风险,即使基线无衰弱。
  • 衰弱评估与共病管理不能替代对感染后认知结局的监测。
  • 该研究提示需要进一步干预性研究验证针对感染能否降低痴呆发病率,临床暂不能据此改变感染治疗策略。

局限性

  • Whitehall II使用替代的蛋白质组学衰弱测量和认知下降作为替代结局,结果精度较低。
  • 观察性设计不能确立严重感染与痴呆的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe infections have been linked to an increased risk of dementia, but whether this association reflects pre-existing conditions that predispose individuals to infections and dementia remains unclear. We assessed whether the association between severe infections and dementia risk is explained by pre-existing frailty, comorbidities, or other age-related physical diseases. METHODS: This prospective, multicohort, observational study included participants without severe infections or dementia (between Dec 19, 2006, and Oct 1, 2010, from the UK Biobank study and between Oct 8, 2002, and Nov 30, 2004, from the Whitehall II prospective cohort study). The primary analysis was conducted in the UK Biobank cohort. Frailty was assessed at baseline using the widely used phenotypic Fried Frailty Scale and comorbidities were assessed using the Charlson Comorbidity Index and 78 age-related diseases. Incident severe (hospital-treated) infections were identified from linked hospital discharge diagnoses. Follow-up included a 5-year exposure period from baseline, a 2-year washout period; and a final period extending to the end of follow-up. Incident dementia occurring after the exposure and washout periods was ascertained from hospital records and death certificates until 2022 (Oct 31 in England, Sept 30 in Scotland, and May 31 in Wales). Participants with a record of dementia during the exposure period or subsequent washout period were excluded. We repeated the main analyses in the Whitehall II study and conducted several supplementary analyses with follow-up until March 1, 2023. FINDINGS: We included 449 223 participants without severe infection or dementia from the UK Biobank study and 6106 from the Whitehall II study. Most participants were White (424 405 [94·5%] in UK Biobank and 5616 [92·0%] in the Whitehall II study). In UK Biobank, the mean age of participants was 56·5 years (SD 8·1), of whom 245 139 (54·6%) were female and 204 084 (45·4%) were male. Of 435 957 participants with dementia follow-up, 23 860 (5·5%) had a record of severe infection during the 5-year exposure period. After a 2-year washout period, the remaining follow-up for dementia occurred for a mean of 6·5 years (SD 1·2). 6756 participants developed incident dementia, corresponding to an incidence of 2·37 (95% CI 2·31-2·43) per 1000 person-years. Adjustment for frailty resulted in no statistically significant attenuation of the infection and dementia association (adjusted hazard ratio [HR] 1·54 [95% CI 1·43-1·67] for presence vs absence of severe infections before adjustment for frailty and 1·49 [1·37-1·61] after adjustment). The association was also evident within a subgroup of non-frail participants (1·34 [1·18-1·53]). Pre-frail and frail participants had a higher corresponding adjusted HR (1·62 [1·47-1·79]). In the Whitehall II study, the mean age of participants was 60·6 years (SD 6·0), of whom 1772 (29·0%) of 6106 were female and 4334 (71·0%) were male. Of 5824 participants available for dementia follow-up, 237 (4·1%) had a record of infection during the 5-year exposure period. After a 2-year washout period, the remaining mean follow-up for dementia was 11·3 years (SD 2·9). 545 incident cases of dementia were recorded (incidence 8·3 per 1000 person-years). Findings in the Whitehall II study, using an alternative proteomic measure of frailty and cognitive decline as a surrogate outcome, were consistent but less precise. INTERPRETATION: Frailty, comorbidities, and other age-related diseases were associated with a higher risk of dementia but did not account for the elevated dementia risk observed after severe infections. Interventional research to test whether targeting infections lowers dementia incidence is needed. FUNDING: Finnish Medical Foundation, Päivikki and Sakari Sohlberg Foundation, Research Council of Finland, Wellcome Trust, UK Medical Research Council, and National Institutes of Health.

来源:Lancet Healthy Longev,查看原文。版权归原作者所有。

引用

  1. Sipilä PN, Pentti J, Frank P, et al. The role of frailty and comorbidities in severe infections and the risk of dementia: a prospective, multicohort, observational study. Lancet Healthy Longev. 2026. PMID: 41969011. doi:10.1016/j.lanhl.2026.100826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。